Oncology / Five Industry R&D Experts on the ‘Golden Age’ of Cancer Drug Discovery
The oncology field has exploded in the past 20 years and pharma companies now have a wide range of approaches available to them as they look to identify, treat, and…
Top Stories
Download / New Turkey Pharma Country Report 2021
On the verge of its 100th anniversary, the Republic of Turkey appears to be approaching a decisive moment in the trajectory of its healthcare industry. With a comprehensive social security system covering over 95 percent of the population already in…
Hong Kong / HKEX Continues Biotech Momentum in Q3 2021
Despite a “turbulent macro backdrop,” the strong momentum in Hong Kong’s IPO market has continued in the third quarter of 2021, driven to a large extent by new biotech listings.…
France / Owkin Becomes Unicorn; Sanofi/Baidu Tie-up for mRNA Algorithm; New Deals for Pierre Fabre & Abionyx
The latest news from French pharma, including AI-based biotech Owkin’s new status as a USD one billion-valued unicorn following fresh investment from Sanofi. Also included is another deal for Sanofi,…
CAR-T in Europe / EBMT's Nicolaus Kröger on GoCART Coalition & EU Harmonisation
Building on points developed in his 2020 PharmaBoardroom interview, Professor Nicolaus Kröger of the European Society for Blood and Marrow Transplantation (EBMT) outlines the progress made by the multi-stakeholder GoCART…
Pharma Faces / Zealand's Emmanuel Dulac Targeting 5 Commercialised Products by 2025
Although Zealand Pharma has been around for 23 years, it has made rapid progress since French national Emmanuel Dulac took the helm as president and CEO in April 2019, with…
Global / The WHO Pandemic Treaty & Three Key Lessons from the COVID-19 Response
The World Health Assembly Special Session on a Pandemic Treaty, which will convene health ministries from around the world in Geneva next week, offers a unique opportunity to take a…
Latest Reports
In Conversation
Marianne Pilgaard – CEO, Trial Nation, Denmark
Trial Nation is a non-profit public-private partnership organisation consisting of all five Danish regions, the Ministry of Industry, Business and Financial Affairs, the Ministry of Health, the umbrella organisations for patient organisations and physicians respectively, and several life science companies dedicated to running clinical trials in Denmark. CEO Marianne Pilgaard outlines Trial Nation’s purpose and key milestones, Denmark’s fundamentals as…
Sameh ElFangary – Country President GCC &…
Sameh ElFangary, Country President for GCC and Pakistan at AstraZeneca, highlights AstraZeneca’s alignment with, and commitment to, Saudi Arabia’s Vision…
Henrik Jespersen – Senior Vice President, Systematic
Henrik Jespersen introduces software and systems provider Systematic’s work in the healthcare space, where the Danish firm looks to help…
Focus on Saudi Arabia
Cabinet Reshuffle Sees New Minister of Health for Saudi…
In a recent royal decree, Saudi Arabia has appointed Fahad Al-Jalajel as its Minister of Health, replacing Dr Tawfiz Al-Rabia who had served since 2016. Here, we give a quick…
3 Regional Pharma Managers on their Middle East Go-To-Market…
The Middle East and Africa (MEA) region is vast and is predominantly composed of emerging countries with varying levels of income and healthcare infrastructure. Here, three regional managers for pharma…
Lilly Signs Saudi MoU for Insulin Manufacturing
Saudi Arabia has one of the highest rates of diabetes in the world – over 17 percent of the population are diabetic – making the supply of insulin products a…
Saudi Arabia’s Vision 2030 Healthcare Transformation…
Saudi Arabia’s ambitious Vision 2030 economic transformation plan aims at transitioning the Middle East’s largest economy away from an over-reliance on fossil fuels and into a more diversified modern nation.…
Read more: Saudi Arabia >>
Focus on USA
NORD’s Breakthrough Summit: Listening to the Rare Disease…
The National Organization for Rare Disorders (NORD) is set to host its annual Rare Diseases and Orphan Products Breakthrough Summit on October 18-19th. Ahead of the Summit, the Chair of…
USA: Drug Innovations Are Delivering for Patients; We Need…
John M. O’Brien, recently appointed president and CEO of the US National Pharmaceutical Council, calls for innovation in benefit design reform to match the unparalleled speed and ingenuity with which…
2021 Drug Formulary Exclusions Continue to Reduce Therapy…
Susan L. Lang outlines how pharma companies can navigate drug formulary exclusions, numbers of which have been rising in recent years, and ensure that newly FDA approved medicines can make…
Biden’s New FDA Pick Not Without Controversy
Almost ten months into his presidency, Joe Biden has announced his pick to lead the US Food and Drug Administration (FDA). If confirmed by the Senate, the nominee, Dr Robert…
Read more: USA >>
Focus on Vaccines
BioNTech to Build Africa’s First mRNA Manufacturing…
Three months after the World Bank announced a EUR 600 million loan to South Africa’s Aspen Pharmacare, the African continent has received more good news as it seeks to increase…
Solidarity: How COVID-19 Brought the Turkish R&D…
As an upper-middle-income country with an emerging economy, Turkey could not invest billions in COVID-19 vaccine R&D, but a strong research ecosystem and willing industry allowed it to kickstart multiple…
UK Pharma News: AstraZeneca Creates COVID Vaccines Unit; GSK…
The latest news from UK pharma, including AstraZeneca’s decision to create a dedicated business unit for its COVID-19 vaccines, GSK’s raised profits forecast, and CDMO Almac’s move to create over…
Pharma Manufacturing in Africa: An Opportunity to Strengthen…
Medicines for Africa's Lenias Hwenda highlights the vast gaps in COVID-19 vaccine access globally, especially in Africa where just six percent of the population has been vaccinated. Hwenda argues that…
Read more: Vaccines >>
Focus on Europe
Sustainability & Pharma Procurement in Europe: Are You…
In the wake of the 2021 United Nations Climate Change Conference (COP26), sustainability is once more a hot-button issue across all industries, including pharma. Here, Marco Rauland, vice president global…
France Pharma Roundup: Owkin Becomes Unicorn; Sanofi/Baidu…
The latest news from French pharma, including AI-based biotech Owkin’s new status as a USD one billion-valued unicorn following fresh investment from Sanofi. Also included is another deal for Sanofi,…
Peptides: Technological Maturity Leading to Big Investments…
With advances in technology, an increasing number of stable peptide-based therapeutics are being brought to market today across a wide range of therapeutic areas. Through expert insight, we explain why…
Pharma Faces: Zealand’s Emmanuel Dulac Targeting 5…
Although Zealand Pharma has been around for 23 years, it has made rapid progress since French national Emmanuel Dulac took the helm as president and CEO in April 2019, with…
Read more: Europe >>
Focus on Turkey
Turkey: Clinical Trial Fundamentals
Becoming the clinical trials country leader in the region has been set as a primary goal for Turkey’s pharma industry to achieve global competitiveness. The government’s strategy is to increase…
Global Competitiveness: Where & Why Turkish Pharma Is…
When the Turkish Ministry of Health implemented its strategy to transition from import pharmaceuticals to manufacturing them at home in 2016, the local industry leveraged the situation to invest in…
GEN: From Niche Distributor to Public Company
Few Turkish companies are experiencing such a transformational moment as GEN. In 2021 alone, the Ankara-based organization made its public debut on the Istanbul Stock Exchange and signed an exclusive…
Solidarity: How COVID-19 Brought the Turkish R&D…
As an upper-middle-income country with an emerging economy, Turkey could not invest billions in COVID-19 vaccine R&D, but a strong research ecosystem and willing industry allowed it to kickstart multiple…
Read more: Turkey >>
Focus on APAC
Asian Biotech: Experts Talk Regulation, Infrastructure,…
Asia has experienced a biotech boom in the past five years. In 2020, almost 50 percent of the region’s clinical trials were led by biotechs and by 2025, biotech-led clinical…
Australia Aiming Targeted Therapies Toward Truly…
In conversation in the November issue of DIA’s Global Forum magazine, Australian Pharmaceutical medical and scientific Professionals Association (APPA) Past President David Grolman highlights the contributions that Australia is already…
Regulatory Cooperation & Joint Assessments in ASEAN
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia's National Pharmaceutical Regulatory Agency; Tharnkamol Chanprapaph of the Thai FDA; and Samvel Azatyan, Valerio Reggi, and…
South Korea’s Top COVID-19 Vaccine Companies
Amid global supply shortages and shipment delays for COVID-19 vaccines, South Korea has launched an ambitious 2.2 trillion won (USD 1.9 billion) investment plan to become one of the world’s…